Coccidioidomycosis and histoplasmosis are endemic mycoses caused by the species and , respectively. While these fungal infections are often associated with immunocompromised individuals, they pose significant risks to immunocompetent hosts. This review comprehensively analyzes these infections in immunocompetent individuals, focusing on clinical features, diagnostic approaches, and management strategies. The current understanding of coccidioidomycosis and histoplasmosis in immunocompetent individuals includes their clinical presentations, diagnostic methodologies, and treatment options. A literature review encompassed recent studies, clinical guidelines, and expert opinions. Data were analyzed to highlight critical aspects of the clinical manifestations, diagnostic processes, and management of these infections in immunocompetent patients. Coccidioidomycosis typically presents with pulmonary symptoms that may range from mild to severe and can include chronic and disseminated forms. Histoplasmosis also presents a spectrum of pulmonary symptoms with the potential for extrapulmonary dissemination. Diagnostic approaches for both infections involve clinical evaluation, serological tests, culture, and imaging studies. Management strategies include antifungal therapies such as fluconazole and itraconazole for coccidioidomycosis and itraconazole and amphotericin B for histoplasmosis, with treatment duration and monitoring tailored to the severity of the infection. Coccidioidomycosis and histoplasmosis can significantly affect immunocompetent individuals, with clinical presentations varying widely from mild to severe. Accurate diagnosis and appropriate management are crucial for optimal outcomes. This review underscores the importance of awareness and timely intervention in managing these endemic mycoses and highlights the need for continued research into better diagnostic and therapeutic approaches.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11443987PMC
http://dx.doi.org/10.7759/cureus.68375DOI Listing

Publication Analysis

Top Keywords

coccidioidomycosis histoplasmosis
16
immunocompetent individuals
16
histoplasmosis immunocompetent
8
clinical features
8
endemic mycoses
8
infections immunocompetent
8
diagnostic approaches
8
management strategies
8
clinical presentations
8
pulmonary symptoms
8

Similar Publications

Disseminated histoplasmosis from western Mexico-rethinking our geographic distribution of endemic fungal species: a case report and review of literature.

J Med Case Rep

November 2024

Division of Pediatric Infectious Diseases, Memorial Care Miller Children's & Women's Hospital Long Beach, Clinical Professor of Pediatrics, University of California Irvine Department of Pediatrics, Irvine, CA, USA.

Background: Histoplasma is a fungal pathogen found in many parts of the world. In North America, its distribution is traditionally thought to be endemic to the Ohio and Mississippi River valleys. Development of histoplasmosis after Histoplasma exposure is related to degree of inoculum exposure and susceptibility, for example, immunocompromised status.

View Article and Find Full Text PDF

Coccidioidomycosis and histoplasmosis are endemic mycoses caused by the species and , respectively. While these fungal infections are often associated with immunocompromised individuals, they pose significant risks to immunocompetent hosts. This review comprehensively analyzes these infections in immunocompetent individuals, focusing on clinical features, diagnostic approaches, and management strategies.

View Article and Find Full Text PDF

Diagnosis of Human Endemic Mycoses Caused by Thermally Dimorphic Fungi: From Classical to Molecular Methods.

J Fungi (Basel)

September 2024

Infectious and Tropical Diseases Research Group (e-INTRO), Biomedical Research Institute of Salamanca-Research Centre for Tropical Diseases at the University of Salamanca (IBSAL-CIETUS), Faculty of Pharmacy, University of Salamanca, 37007 Salamanca, Spain.

Article Synopsis
  • Human endemic mycoses are serious fungal infections that can change their form in response to heat, posing risks to both healthy and immunocompromised individuals.
  • Diagnosing these infections is challenging due to overlapping symptoms, limited traditional diagnostic methods, and lack of access to reliable testing in affected regions.
  • The review discusses key information about these fungi, traditional diagnostic techniques, their pros and cons, and the need for improved diagnostic strategies to lessen the health impact in endemic areas.
View Article and Find Full Text PDF
Article Synopsis
  • A 69-year-old woman with a history of autoimmune conditions was admitted to the emergency department after experiencing fever, malaise, and confusion, which she initially developed while visiting her son in Tennessee, where mold exposure occurred.
  • Laboratory tests confirmed she had both histoplasmosis and coccidioidomycosis, fungal infections that often affect immunocompromised individuals.
  • After treatment with intravenous amphotericin B, her condition improved, allowing her discharge on oral itraconazole with plans for follow-up care.
View Article and Find Full Text PDF
Article Synopsis
  • Less than 0.5% of patients with inflammatory bowel disease or rheumatoid arthritis developed an invasive fungal infection (IFI) within a year of starting TNF-alpha therapy.
  • Histoplasmosis was identified as the most frequently occurring type of IFI among these patients.
  • The incidence of IFIs varied depending on factors like geographic region, existing health conditions, and the use of specific immunosuppressive drugs.
View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!